Researchers examined the safety and efficacy of daily vs weekly levothyroxine therapy for hypothyroidism in young and middle aged adults.
Synthroid was associated with an 11% lower likelihood of having out-of-range TSH lab values vs generic levothyroxine.
A 28-year-old male patient, otherwise in good health, presented with acute onset vertigo, nausea, and vomiting resulting from exogenous testosterone use.
Researchers noted a significant increase in serum vitamin D and significant reductions in TSH following 3 months of vitamin D supplementation.
Patients on HAART may require additional metabolic monitoring for cardiovascular issues.
A patient presented with intentional 10-pound weight loss, suppressed thyroid-stimulating hormone, and increased FT4 and TT3 levels.
The patient presented with symptoms consistent with adrenal deficiency following 18 years of topical steroid application.
The combined treatment regimen of metformin and liraglutide led to complete remission in 74% of patients with new onset type 2 diabetes.
More patients receiving empagliflozin and linagliptin combination therapy were able to reach HbA1c goals compared with those patients receiving monotherapy.
Patients with HIV and abdominal fat who received tesamorelin experienced positive changes in fasting blood glucose and glycated hemoglobin A1c.
Physicians need to be aware of silent thyroiditis as a rare but serious side effect of lithium therapy.
Severe hypoglycemia was found to be an important risk factor for increased risk of short-term mortality in patients with type 2 diabetes.
There has been growing concern that testosterone replacement therapy is associated with adverse cardiovascular outcomes.
The relative risk for developing preeclampsia, determined using waist-to-hip ratio, was 3.317 vs 2.418 using BMI.
Early initiation of insulin therapy in patients with type 2 diabetes improved HbA1c, fasting blood sugar, postprandial blood sugar, and BMI.
Investigators examined an 83-year-old male patient who developed severe hypocalcemia induced by denosumab.
After 24 months, bone mineral density was statistically different from baseline.
Patients with type 1 diabetes had higher mortality rates when admitted for acute myocardial infarction compared with patients with type 2 diabetes.
Patients with comorbid congestive heart failure who received parenteral nutrition had higher mortality rates.
Women who required insulin for gestational diabetes had an increased risk of developing postpartum diabetes.
Bone ultrasonography is able to detect tenofovir-induced bone loss in patients with HIV.
More than 40% of adolescents had either prehypertension or hypertension.
First look at research being presented at AACE 2017.
Endocrinology Advisor Articles
- Trends in Cardiovascular Deaths for US Adults With and Without Diabetes
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Comparing Efficacies of Second-Line Treatments in Type 2 Diabetes
- Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- Behavioral Weight Loss Interventions May Prevent Obesity
- Disaster Preparedness 101: Physician Resources for Patients
- Assessing the Environmental Impact of the Healthcare Industry
- Medical Schools Phase Out Lectures as Education Shifts Outside the Classroom
- Clonidine Testing Is Safe and Reliable for Diagnosing Growth Hormone Deficiency